No Data
No Data
DIFFER GP AUTO (06878.HK) has postponed the revised debt arrangement hearing to February next year.
DIFFER GP AUTO (06878.HK) announced that in order to allow more time to assess the impact of the litigation in China on the debt arrangement, an application was made to the court on the 5th of this month. The court, after considering the company's application during the hearing last Friday (the 13th), ordered to further postpone the revised debt arrangement hearing, now scheduled for 10:00 AM on February 11, 2025.
Eternal Health Bio-B (06978.HK) has received breakthrough therapy designation for its leukemia injection.
Eternal Pharmaceutical - B (06978.HK) announced that its product CAR-T–19 injection has received breakthrough therapy designation from the National Medical Products Administration's Drug Evaluation Center for the treatment of patients aged 25 and below with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). This designation is based on the reliable clinical efficacy and safety data of CAR-T–19 injection. It will accelerate the clinical development of CAR-T–19 injection and expedite its availability to patients. CAR-T–19 injection is intended for the treatment of children and young adults under 25 years old (including 25 years) with B-ALL.
Differ GP Auto (06878): Share consolidation and change of the trading unit has failed.
Differ gp auto (06878) announced that the conditions for share consolidation (i) have not been met. Therefore, the share consolidation and...
Differ Group Auto to Use Entire Proceeds From February Placement to Stay Operational
Express News | Yidingfeng's TCU and VCU products developed based on Guoxin technology chips have been designated by many vehicle manufacturers.
Futian Holdings announced that Peking Xinghua has been appointed as the auditor.
Futian Holdings (08196) announced that the company's Audit Committee and board of directors have received a letter from Zhonghui Anda Certified Public Accountants Co., Ltd. (Zhonghui Anda) dated November 19, 2024, regarding their resignation as the group's auditor, effective from November 19, 2024. The reason for the resignation is the inability of the company and Zhonghui Anda to reach a consensus on the proposed expenses for the year ending December 31, 2024; and the partner responsible for auditing the group's financial statements for the year ended December 31, 2023, and the audit team members have left Zhonghui Anda and joined another accounting firm. According to
No Data